FDA Approved: GEMFIBROZIL — Supplemental Application (Exelan Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Gemfibrozil submitted by Exelan Pharmaceuticals, Inc., likely updating the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Hypertriglyceridemia
• Mixed Dyslipidemia

Drugs mentioned

• Gemfibrozil (Lopid) (Gemfibrozil)

Snippet

SUPPL AP for GEMFIBROZIL (GEMFIBROZIL)